FDA Lupus Trial Design Guidance Will Go To Advisory Committee In Fall
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA is planning to present its draft guidance on lupus clinical trial design at a meeting of the Arthritis Advisory Committee this fall.